ATHE Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

a month ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference

a month ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System

a month ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System

2 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

2 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

2 months ago - By: Benzinga - Mentions: SSII DBVT NDRA RCKT ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

2 months ago - By: Benzinga - Mentions: KIDS VNRX JAGX CUE ...

12 Health Care Stocks Moving In Thursday's After-Market Session

2 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

2 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

2 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

2 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

3 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting

3 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Raises A$20.0 million in Strategic Placement

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Raises A$20.0 million in Strategic Placement

3 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics to Present at the Biotech Showcase

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics to Present at the Biotech Showcase

5 months ago - By: ALTERITY THERAPEUTICS LIMITED

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

5 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

5 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

5 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

5 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

5 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

6 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

6 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

7 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Prominently Featured at the International MSA Congress

7 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Prominently Featured at the International MSA Congress

7 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

7 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

7 months ago - By: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

7 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: ASX -

ALTERITY THERAPEUTICS-ADR (ATHE) Stock News

ATHE Latest News, Press Relases and Analysis